Weakened endorsements in settings of normal EF and mild-moderate LV dysfunction may cause harm
An abundance of promising studies are on the horizon
Cleveland Clinic experience is applicable to other laboratories
Freely accessible LEADconnection.org is a one-stop shop for advice and more
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advanced transcatheter options have expanded patient candidacy
Two major trials promise key progress against the last unaddressed major risk factor
Network proximity and EHR analyses identify diabetes drug as a top candidate for risk reduction
Large database analysis finds no rise in in-hospital mortality relative to younger patients
Gains are associated with clinical and biomarker benefits in obstructive HCM
Sophisticated in vivo modeling can enhance device development and therapy testing
Advertisement
Advertisement